282 related articles for article (PubMed ID: 34004371)
1. The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.
Scholtes GK; Sawyer AM; Vaca CC; Clerc I; Roh M; Song C; D'Aquila RT
Transl Res; 2021 Nov; 237():1-15. PubMed ID: 34004371
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H.
Ito F; Alvarez-Cabrera AL; Kim K; Zhou ZH; Chen XS
Nat Commun; 2023 Aug; 14(1):5241. PubMed ID: 37640699
[TBL] [Abstract][Full Text] [Related]
5. Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
Perez-Bercoff D; Laude H; Lemaire M; Hunewald O; Thiers V; Vignuzzi M; Blanc H; Poli A; Amoura Z; Caval V; Suspène R; Hafezi F; Mathian A; Vartanian JP; Wain-Hobson S
Sci Rep; 2021 Apr; 11(1):7893. PubMed ID: 33846459
[TBL] [Abstract][Full Text] [Related]
6. Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
McDonnell MM; Karvonen SC; Gaba A; Flath B; Chelico L; Emerman M
PLoS Pathog; 2021 Jun; 17(6):e1009523. PubMed ID: 34170969
[TBL] [Abstract][Full Text] [Related]
7. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
8. Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.
Stupfler B; Verriez C; Gallois-Montbrun S; Marquet R; Paillart JC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33916704
[TBL] [Abstract][Full Text] [Related]
9. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.
Liu W; Xin H; Eckert DT; Brown JA; Gnarra JR
Oncogene; 2011 Jan; 30(1):21-31. PubMed ID: 20802534
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.
Li Z; Na X; Wang D; Schoen SR; Messing EM; Wu G
J Biol Chem; 2002 Feb; 277(7):4656-62. PubMed ID: 11739384
[TBL] [Abstract][Full Text] [Related]
12. The COP9/signalosome increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-mediated hypoxia-inducible factor-alpha ubiquitination.
Miyauchi Y; Kato M; Tokunaga F; Iwai K
J Biol Chem; 2008 Jun; 283(24):16622-31. PubMed ID: 18424433
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
Hou S; Lee JM; Myint W; Matsuo H; Kurt Yilmaz N; Schiffer CA
J Biol Chem; 2021 Aug; 297(2):100909. PubMed ID: 34171358
[TBL] [Abstract][Full Text] [Related]
14. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.
Corn PG; McDonald ER; Herman JG; El-Deiry WS
Nat Genet; 2003 Nov; 35(3):229-37. PubMed ID: 14556007
[TBL] [Abstract][Full Text] [Related]
15. HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
Zhang Z; Perković M; Gu Q; Balakrishnan K; Sangwiman A; Häussinger D; Lindemann D; Münk C
Virology; 2021 Feb; 554():17-27. PubMed ID: 33333348
[TBL] [Abstract][Full Text] [Related]
16. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
17. Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.
Hu Y; Knecht KM; Shen Q; Xiong Y
FEBS J; 2021 Jun; 288(11):3407-3417. PubMed ID: 32893454
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Patterson AP
J Biol Chem; 2021 Aug; 297(2):100889. PubMed ID: 34181944
[TBL] [Abstract][Full Text] [Related]
19. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
20. [APOBEC3s: history of an antiviral and mutagenic protein family].
Verriez C; Marquet R; Paillart JC; Stupfler B
Virologie (Montrouge); 2020 Dec; 24(6):381-418. PubMed ID: 33441290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
